Risque thrombotique au cours des myélodysplasies avec thrombocytose : la cytogénétique est un facteur de risque potentiel
Thibault Comont(Institut universitaire du cancer de Toulouse Oncopole), O. Beyne-Rauzy(Hôpital Purpan), Pierre Cougoul(Hôpital Purpan), A. Hébrard(Hôpital Purpan), D. Adoué, S. Ollier(Institut universitaire du cancer de Toulouse Oncopole), Loïc Lelièvre(Hôpital Purpan), V. Demas(Hôpital Purpan), Jonathan Khalifa(Inserm)
Cited by 0
Related Papers
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study
|The Lancet Infectious Diseases|2017|587
Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies
|Journal of Allergy and Clinical Immunology|2017|316
Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults
|Journal of Thrombosis and Haemostasis|2018|138
Acute interstitial nephritis related to immune checkpoint inhibitors
|British Journal of Cancer|2016|103